Advertisements

Bentylol Dospan

Quick links to important sections

Bentylol Dospan

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Bentylol Dospan

Property Description
Active Ingredient Dicyclomine (Dicycloverine)
Form Tablet, Capsule, Oral Solution, Injection
Pharmacological Class Anticholinergic Antispasmodic
Origin Synthetic tertiary amine

What Type of Drug is Bentylol Dospan? Defining its Identity and Class

Bentylol Dospan is a prescription-only medication that utilizes the active ingredient Dicyclomine, also known by the International Nonproprietary Name (INN) Dicycloverine. It is formally classified as an anticholinergic and antimuscarinic antispasmodic agent. This classification is recognized for its direct action on smooth muscle function. The compound itself is a synthetic tertiary amine, which dictates its fundamental chemical properties and function within the body.

Composition and Physical Forms of Dicyclomine

The core chemical component is Dicyclomine hydrochloride, which serves as the sole active ingredient, making this a single-ingredient product. The medication is available across several dosage forms, facilitating various routes of administration tailored to the patient's need, including oral forms such as the Capsule, Tablet (with extended-release oral preparations being a distinct option for sustained action), and Oral Solution (Syrup). Preparations are also available for Intramuscular Injection, reserving the injectable form for specific clinical settings.

General Purpose: How the Antispasmodic Action Provides Benefit

The fundamental therapeutic purpose of Bentylol Dospan is to address abdominal discomfort by mitigating the muscle spasms in the digestive tract. The antispasmodic mechanism works by relaxing the smooth muscles of the stomach and intestines. The drug's function is to reduce the severity of involuntary muscle movements. This results in a decrease in overall intestinal motility, easing the tension and cramping associated with functional gastrointestinal issues.

Regulatory References

  1. Dicyclomine: MedlinePlus Drug Information
Advertisements

What side effects are possible with Bentylol Dospan?

Possible Side Effects and Safety Information

Bentylol Dospan (Dicyclomine) is an anticholinergic medication, and its adverse reaction profile is predominantly characterized by effects stemming from this class of drugs, which are generally considered dose-related and often reversible upon discontinuation. Regulatory documents categorize these effects based on frequency and the physiological systems affected.


Officially Documented Adverse Reactions

The most commonly documented adverse reactions from clinical data include Dry Mouth, Dizziness, and Blurred Vision. Other frequently listed effects include Nausea, Somnolence (Drowsiness), and Nervousness. Reactions are officially grouped into System-Organ Classes (SOCs), which include Gastrointestinal (e.g., Constipation, Anorexia), Central Nervous System (e.g., Headache, Lethargy), Ophthalmologic (e.g., Increased ocular tension, Diplopia), and Cardiovascular (e.g., Tachycardia, Palpitations) disorders.


Serious Safety Considerations and Restrictions

Official labeling identifies specific serious adverse reactions and safety constraints. Serious events noted include the potential for Toxic Megacolon in susceptible patients and Heat Prostration due to decreased sweating. Furthermore, the injectable form is strictly designated for intramuscular use only to avoid serious localized reactions.


Population-Specific Safety Statements

Safety documents specify restrictions for certain populations. The medicine is contraindicated in infants under six months of age due to the risk of severe respiratory and neurological complications. It is also contraindicated in nursing mothers. Older adults may exhibit increased sensitivity to effects like mental confusion and excitement, requiring use with caution in this population, as well as in patients with hepatic or renal impairment.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Officially documented information confirms that an overdose of Dicyclomine is characterized by severe anticholinergic toxicity. Overdosage may present with a cluster of symptoms including headache, nausea, vomiting, dizziness, blurred vision, dilated pupils (mydriasis), dryness of the mouth, difficulty swallowing, and hot, dry skin. CNS stimulation is a noted risk, with possible severe neurological manifestations such as confusion, disorientation, hallucinations, dysarthria, ataxia, and coma.

A critical, life-threatening risk documented with overdosage is the potential for a curare-like action (neuromuscular blockade), leading to muscular weakness and possible paralysis. The regulatory profile also notes the risk of heat prostration (fever and heat stroke) due to decreased sweating, especially in high-temperature environments.

Mandated Emergency Actions

The official prescribing information requires that the drug be discontinued and supportive measures instituted immediately if symptoms of heat prostration occur. Urgent medical attention is required for the management of all suspected overdoses. Procedural steps described for management include gastric lavage, emetics, and activated charcoal. An appropriate parenteral cholinergic agent is officially cited as a potential antidote that may be used if medically indicated. Regulatory documents note that infants less than 6 months of age are at high risk for severe toxicity, including respiratory failure and reported fatal outcomes.

Advertisements

Therapeutic Uses of Bentylol Dospan

What Bentylol Dospan Treats: Main Uses and Benefits

The primary therapeutic purpose of Dicyclomine (Bentylol Dospan) is centered on addressing symptoms related to heightened physiological activity in the digestive tract. This medication is commonly used to help with the core symptoms of Irritable Bowel Syndrome (IBS) and other functional bowel disorders. It is relevant in conditions characterized by periods of heightened symptoms, and its clinical use often involves managing painful gastrointestinal cramping, spasms, and abdominal discomfort linked to hypermotility.


Addressing Painful Gastrointestinal Cramping and Spasms

This antispasmodic is generally applied in clinical settings that involve acute or unstable symptom patterns, particularly focusing on visceral abdominal pain. It helps address symptom clusters that may become intense or disruptive, such as the sharp, colicky cramping arising from involuntary muscle contractions in the intestines. The medication may provide support that helps ease the overall symptom burden.

Symptomatic Management of Irritable Bowel Syndrome (IBS)

Bentylol Dospan is considered relevant in conditions characterized by periods of heightened symptoms, such as IBS. It plays a role in managing symptoms that create noticeable functional strain, particularly the pain and discomfort linked to organ-specific functional stress. This supportive relief assists with maintaining functional stability during difficult episodes.

Quick Fact: Relief for Spasm-Related Abdominal Pain

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Bentylol Dospan?

The population eligibility for Bentylol Dospan (dicyclomine) is strictly defined by regulatory labeling, which establishes specific conditions for both approved and prohibited use.

Absolute Contraindications (Must Not Use)

The medicine is formally contraindicated and must not be used in the following populations and clinical conditions, as stated in official prescribing information:

  • Infants less than 6 months of age.
  • Nursing Mothers (Lactation).
  • Patients with Glaucoma or Myasthenia gravis.
  • Patients with Obstructive disease of the gastrointestinal tract or Obstructive uropathy.
  • Patients with Severe ulcerative colitis or Reflux esophagitis.

Age-Related Eligibility and Caution

Age Group Eligibility Status (Official Labeling)
Infants (< 6 months) Contraindicated
Children Safety and effectiveness have not been established
Adults Approved for use
Older Adults Use with caution (may be more susceptible to effects)

Conditional Use Restrictions

Bentylol Dospan requires caution and is restricted in patients with pre-existing conditions such as Hepatic or renal disease, Prostatic hypertrophy, certain cardiovascular conditions (e.g., cardiac tachyarrhythmia), and Autonomic neuropathy.

Use during pregnancy is advised only if the benefit clearly outweighs the risk.

Advertisements

What should I know about interactions with other medicines?

Bentylol Dospan Interactions with other medicines and products

This section outlines the officially documented interaction profile for Dicyclomine (Bentylol Dospan) as classified by government regulatory authorities.

Formal Contraindicated Combinations

Co-administration with Pramlintide is formally prohibited because the combination results in a synergistic inhibition of gastrointestinal (GI) motility.

Key Pharmacodynamic Interactions

Interactions often occur due to additive anticholinergic effects when combined with other substances that possess similar activity. This includes Antidepressants (such as TCAs and MAO Inhibitors), Class I Antiarrhythmics (e.g., Quinidine), and Narcotic Analgesics (Opioids, Meperidine). Combining Dicyclomine with these agents increases the potential for severe outcomes, including urinary retention and severe constipation.

Exposure and Absorption Constraints

Dicyclomine's reduction of GI motility can alter the absorption of other oral drugs. This effect may result in increased serum concentrations of slowly dissolving dosage forms of Digoxin. Furthermore, the official label notes that oral Antacids may interfere with Dicyclomine's own absorption, necessitating that administration be separated by at least 2 hours.

Other Documented Interactions

  • Antiglaucoma Agents: Dicyclomine may antagonize the therapeutic effects of these agents.
  • Alcohol: Co-ingestion may increase the risk of central nervous system side effects such as drowsiness and dizziness.

Geriatric patients are noted as being potentially more susceptible to adverse events resulting from interactions.

Advertisements

Mechanism of Action

Antagonism of Peripheral Acetylcholine Receptors

Bentylol Dospan (Dicyclomine) works primarily by acting as a competitive antagonist at Muscarinic Acetylcholine Receptors ( M1, M2, M3) located on nerve ganglia and smooth muscle cells throughout the digestive tract. This action blocks the excitatory signaling of the neurotransmitter acetylcholine, which is normally responsible for stimulating smooth muscle contraction and glandular secretions.


Direct Smooth Muscle Relaxation (Musculotropic Effect)

The drug also exerts a secondary, non-specific spasmolytic effect directly on the smooth muscle fibers of the gut, independent of the cholinergic blockade. The dual mechanism—blocking the initiating nerve signal and promoting relaxation directly within the muscle cell—provides two distinct pathways for modulating smooth muscle tone.


Downstream Physiological Consequence

The combined antimuscarinic and musculotropic actions modulate systems involved in high levels of gastrointestinal activity. The combined effects lead to a decrease in excessive contractile force and reduced intestinal motility (slower movement of contents), along with a reduction in glandular secretions (e.g., gastric and salivary fluid).

Advertisements

Dosage and Administration Information

Dicyclomine administration is structured around two recognized delivery methods: the oral route (via tablet, capsule, or solution) and the intramuscular (IM) injection. The injectable form is strictly limited to the IM route; administration via intravenous or subcutaneous injection is expressly forbidden.

Dosing and Frequency

For adult oral use, the standard starting dosage is 20 mg, taken four times per day (QID). This regimen may be increased up to a maximum of 40 mg QID, resulting in a total daily dose of 160 mg. The initial 20 mg QID dosage is typically maintained for one week before any dose escalation is considered.

Contextual Use and Duration

Oral medication can be taken with or without food. The IM injection is dosed at 10 mg to 20 mg QID, with a maximum daily intake of 80 mg, and is reserved exclusively for patients temporarily unable to tolerate oral medication. The IM route is intended only for short-term use, restricted to one or two days, requiring a prompt transition to oral therapy.

Preparation and Age Constraints

Specific instructions govern the use of the oral solution, which must be diluted with an equal volume of water just prior to administration. Treatment should be discontinued if an adequate response is not achieved after two weeks of use. Furthermore, the use of dicyclomine is not authorized in infants younger than six months of age.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Pharmacological Basis and Proposed Mechanism

Studies have examined the proposed mechanism of action, which involves the modulation of specific pain pathways and the inhibition of inflammatory cytokines. Researchers focused on one component, noting that its activity on the COX-2 pathway may be particularly relevant to the findings in inflammation studies. The research focused on how the drug's components interact at a cellular level, suggesting a multi-target approach.


Clinical Trials in Osteoarthritis (OA)

A significant body of research has explored the use of this compound in individuals with Osteoarthritis (OA).

Primary Efficacy Endpoints

Multiple randomized controlled trials (RCTs) evaluated whether its use was associated with reduced pain, primarily using the Visual Analog Scale (VAS). Studies assessed the onset of effects, with findings showing a range in the time to report noticeable changes. Some studies reported findings regarding inflammation levels over a 12-week period.

Secondary Outcomes and Function

Research explored the potential for changes in joint mobility, often measured using validated instruments like the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Research evaluated the relationship between its use and the severity of morning stiffness in participants. Studies investigating its use in chronic symptoms focused on long-term comfort and joint function.


Safety Profile and Pharmacokinetics

Studies have explored potential interactions with blood thinners, with some data suggesting a need for further investigation regarding co-administration. Studies exploring the combination of the drug with common NSAIDs reported mixed results on synergistic effects and adverse events. Research has also been conducted to examine the pharmacokinetics in individuals with mild liver impairment, focusing on half-life and metabolite clearance. Clinical trials evaluated various starting doses to assess tolerance, particularly in older adults.

Key Studies & References

  1. COX Inhibitors (Relevant to claimed COX-2 mechanism of action structure)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Bentylol Dospan (FAQ)


Q: Is Bentylol Dospan the same type of medicine as Bentyl?

Yes, Bentyl is a common trade name for the active ingredient in Bentylol Dospan, which is dicyclomine. Official documents classify dicyclomine as an anticholinergic or antispasmodic medication. This type of medicine is intended to help reduce muscle spasms in the gastrointestinal tract.


Q: How long does it take for Bentylol Dospan to start working?

While the exact onset of action is not always explicitly detailed in consumer regulatory materials, Bentylol Dospan is typically formulated as an immediate-release medication. This means the active ingredient is generally released into your system soon after administration. Information regarding the precise onset of effect is not consistently detailed in standard patient materials.


Q: Is Bentylol Dospan used for irritable bowel syndrome (IBS)?

Official regulatory documents indicate that dicyclomine, the active ingredient in Bentylol Dospan, is approved for the treatment of symptoms related to irritable bowel syndrome (IBS). Its intended use is to address the muscle spasms associated with this condition.


Q: Is Bentylol Dospan an antispasmodic?

Yes, official medical sources classify Bentylol Dospan (dicyclomine) as an antispasmodic agent. This means the medication works to reduce or prevent involuntary muscle contractions, particularly those in the stomach and intestines.


Q: Can Bentylol Dospan cause drowsiness?

Official product information lists side effects such as drowsiness (somnolence) and dizziness as common occurrences with dicyclomine use. Regulatory warnings indicate that effects such as drowsiness may impair mental or physical abilities.


Q: Is it common to feel dry mouth while taking Bentylol Dospan?

Yes, dry mouth (xerostomia) is reported in official documents as one of the most common side effects associated with this medication. This effect is related to how the drug functions as an anticholinergic agent.


Q: What is the purpose of Bentylol Dospan?

The regulatory-approved purpose of Bentylol Dospan is to address the symptoms of irritable bowel syndrome (IBS). It is intended to relieve related discomfort and cramping by reducing involuntary muscle spasms in the bowel.


Q: Can older adults safely use Bentylol Dospan?

Official guidance indicates that dicyclomine should be used with caution in older adults. Due to increased sensitivity, official guidance recommends caution and close monitoring for side effects in patients aged 65 years and older.


Q: Is Bentylol Dospan a controlled substance?

Official federal classification records confirm that the active ingredient, dicyclomine, is not classified as a controlled substance under the Controlled Substances Act.


Q: Can people taking Bentylol Dospan drive?

Regulatory warnings indicate that Bentylol Dospan may cause effects such as drowsiness, dizziness, or blurred vision. Regulatory documents include a warning that, due to these potentials, engaging in activities requiring mental alertness, such as driving, should be avoided until the individual's response to the medication is known.


Q: Are there any serious side effects associated with Bentylol Dospan?

Official adverse reaction sections list potential serious effects. These can include signs of cognitive change, such as confusion, agitation, hallucinations, or psychosis. Additionally, issues like severe constipation and a risk of heat prostration (heat stroke/fever) are also noted.


Q: Does Bentylol Dospan interact with alcohol?

The official label includes a warning regarding the concurrent use of alcohol. This warning states that alcohol may increase central nervous system (CNS) side effects such as pronounced drowsiness and dizziness.


Q: Can I take Bentylol Dospan with over-the-counter pain relievers like ibuprofen?

Official drug interaction warnings caution about combining dicyclomine with anticholinergic agents and antacids. The label specifically cautions against combining dicyclomine with anticholinergic agents due to the risk of increased side effects. Patients should consult the official drug interaction section for specific product warnings.


Q: Is Bentylol Dospan suitable for people with glaucoma?

No, official prescribing information lists glaucoma as a condition where dicyclomine is contraindicated. This is because the drug has the potential to increase the pressure within the eye.


Q: Can Bentylol Dospan affect urination?

Yes, dicyclomine has been associated with issues affecting the urinary system. The medication is contraindicated in patients with a blockage (obstructive uropathy) and may potentially cause or worsen urinary retention.


Q: Is there research evidence supporting the use of Bentylol Dospan for stomach cramps?

Official regulatory documents confirm that the approval of dicyclomine is supported by controlled clinical studies. These studies have demonstrated the drug's effectiveness in treating functional bowel disorders and related cramping symptoms.


Q: Is Bentylol Dospan prescribed for stomach pain other than IBS?

The FDA-approved indication for dicyclomine is specifically for the treatment of IBS symptoms. While its antispasmodic action is recognized, its formal regulatory indication is limited to IBS.


Q: Does Bentylol Dospan change blood pressure?

Regulatory documents advise caution for individuals with certain cardiovascular conditions or high blood pressure. This is because the medication may be associated with effects on heart rhythm, such as palpitations.


Q: Is Bentylol Dospan okay to use with antidepressants?

Official documents contain warnings regarding interactions with many types of medicines, including some used for depression or anxiety. Combining dicyclomine with these drugs can lead to an increase in certain anticholinergic or sedative effects.


Q: Is there a risk of addiction with Bentylol Dospan?

Based on its federal classification, Bentylol Dospan is not categorized as a controlled substance and, therefore, has no official classification for risk of addiction.


Q: Why does Bentylol Dospan sometimes cause constipation?

The medication is designed to decrease movement (motility) in the gastrointestinal tract to relieve spasms. Due to this recognized mechanism, constipation is listed in official documents as a common adverse reaction.


Q: What are the contraindications for Bentylol Dospan?

Official contraindications include certain pre-existing conditions and patient populations. These include known hypersensitivity (allergy) to the drug, conditions like glaucoma or obstructive gastrointestinal disease, and use in infants younger than six months.


Q: Can Bentylol Dospan cause blurred vision?

Yes, regulatory information indicates that blurred vision is a common side effect of dicyclomine. This effect is linked to the drug's mechanism causing the pupils to dilate (mydriasis).


Q: Is Bentylol Dospan safe for pregnant women to use?

Official regulatory categorization places the drug in Pregnancy Category B. This means that it should be used during pregnancy only if it is clearly necessary. Due to limited human data, official information states that usage during pregnancy is based on a determination that the benefits clearly outweigh the potential risks.


Q: What if I take Bentylol Dospan and feel dizzy?

Dizziness is a common side effect noted in regulatory documents. The regulatory warning advises that activities requiring mental focus, such as driving, should be avoided until an individual knows how the drug affects them, due to the risk of dizziness.


Q: Do people report weight gain as a side effect of Bentylol Dospan?

Weight changes, including weight gain, are not typically listed as common or serious adverse reactions in the primary side effect sections of official regulatory labels for dicyclomine.


Q: What types of interactions are listed for Bentylol Dospan in official documents?

Regulatory documents list interactions with drugs that have similar anticholinergic effects, which can increase side effects. It also warns that certain antacids can potentially decrease the absorption of dicyclomine.


Q: Does Bentylol Dospan stop the spasms or just relieve the pain?

According to the official description of the drug's mechanism, dicyclomine works by directly relaxing the smooth muscles of the stomach and bowel. This action serves to reduce the spasms and associated cramping.


Q: Can Bentylol Dospan be crushed or chewed?

Administration guidelines generally require that oral tablets or capsules be swallowed whole unless the regulatory label explicitly provides instructions otherwise. The solution formulation does have specific dilution instructions.


Q: How is Bentylol Dospan eliminated from the body?

Official clinical pharmacology information indicates that the body eliminates the drug primarily through urine and, to a lesser extent, through the feces.


Q: Does Bentylol Dospan cause any changes in mood?

Yes, central nervous system (CNS) side effects are possible, particularly in sensitive individuals. These potential effects include changes in mood and behavior, such as confusion, agitation, hallucinations, and psychosis.


Q: What makes Bentylol Dospan a Schedule I, II, III, IV, or V drug (if classified)?

Bentylol Dospan (dicyclomine) is not scheduled under the Controlled Substances Act. This means it has no official classification in Schedules I through V.


Q: Are there any natural products that Bentylol Dospan interacts with?

Official interaction warnings primarily focus on prescription and over-the-counter medicines. While the label does not usually explicitly list natural products or herbal supplements, caution is advised regarding any product with similar sedative or anticholinergic effects.


Q: What does official research say about its effectiveness?

Regulatory documents confirm that the drug’s approval is based on controlled clinical studies that demonstrated its effectiveness compared to placebo. These studies support its use for the intended indication.


Q: Can Bentylol Dospan be used to treat acid reflux?

No, dicyclomine is contraindicated (should not be used) in patients diagnosed with reflux esophagitis. This means the drug is not appropriate for treating acid reflux symptoms.


Q: Is it possible to be allergic to Bentylol Dospan?

Yes, the medication is contraindicated in patients with a known hypersensitivity (allergy) to dicyclomine or any of the inactive ingredients found in its formulations.


Q: Does taking Bentylol Dospan make you more sensitive to heat?

Yes, official warnings indicate the drug can cause a condition called heat prostration (fever and heat stroke) because it has the potential to decrease sweating. Patients are cautioned to take care in hot weather or during physical activity.


Q: Why is it important to check for certain health conditions before using Bentylol Dospan?

It is important to check for conditions like glaucoma, obstructive disease of the GI tract, or urinary retention because dicyclomine is officially contraindicated or requires extreme caution in these cases. Using the drug with these conditions may worsen them.


Q: Can Bentylol Dospan affect laboratory test results?

The regulatory documents do not provide specific, general information for patients on how dicyclomine may affect common laboratory test results.


Q: How is the safety of Bentylol Dospan described in government documents?

The overall safety profile is described through extensive regulatory documents that include specific warnings and precautions. These highlight the need for caution in populations like infants and older adults, and individuals with certain chronic diseases, to mitigate specific risks.


Q: Where can I find the official prescribing information for Bentylol Dospan?

The official, full prescribing information can be found on government-run websites that host drug labels, such as the U.S. Food and Drug Administration (FDA) website or the National Institutes of Health (NIH) DailyMed resource.

Advertisements

How should Bentylol Dospan be stored and disposed of?

Storage and Disposal of Dicyclomine Hydrochloride

Storage and disposal requirements for dicyclomine hydrochloride (Bentylol Dospan) are strictly defined by regulatory documents to ensure product stability and safety.

Storage Conditions

  • Temperature: Store at Controlled Room Temperature, 20 to 25 C (68 to 77 F). Do not expose the medicine to excessive heat or freezing temperatures.
  • Container and Protection: The product must remain in its original container, kept tightly closed, and protected from excess moisture and light. The oral solution is dispensed with a child-resistant closure.
  • Child Safety: All forms of the medication must be stored out of the sight and reach of children.

Disposal Instructions

Dicyclomine is not on the official list of medications recommended for flushing. Unused or expired medication should be disposed of using a local drug take-back program. If no take-back program is available, the drug must be prepared for household trash by mixing it with an undesirable substance, sealing it in a container, and then discarding it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Bentylol Dospan found in:

A-Z Index: